607 related articles for article (PubMed ID: 20224314)
1. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD
Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
[TBL] [Abstract][Full Text] [Related]
2. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
3. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2010 Jun; 339(6):543-8. PubMed ID: 20375689
[TBL] [Abstract][Full Text] [Related]
4. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
Howard LL; Patterson ME; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F810-5. PubMed ID: 15585671
[TBL] [Abstract][Full Text] [Related]
5. Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Milani CJ; Kobori H; Mullins JJ; Mitchell KD
Am J Med Sci; 2010 Nov; 340(5):389-94. PubMed ID: 20724906
[TBL] [Abstract][Full Text] [Related]
6. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Vanourková Z; Erbanová M; Thumová M; Opocenský M; Mullins JJ; Kramer HJ; Bürgelová M; Cervenka L
J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
[TBL] [Abstract][Full Text] [Related]
7. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Mitchell KD; Mullins JJ
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
Erbanová M; Thumová M; Husková Z; Vanecková I; Vanourková Z; Mullins JJ; Kramer HJ; Bürgelová M; Rakusan D; Cervenka L
J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
[TBL] [Abstract][Full Text] [Related]
10. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Sedláková L; Kikerlová S; Husková Z; Červenková L; Chábová VČ; Zicha J; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Krátký V; Červenka L; Kopkan L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054426
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
12. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
Patterson ME; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Opay AL; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.
Vanourková Z; Kramer HJ; Husková Z; Vanecková I; Opocenský M; Chábová VC; Tesar V; Skaroupková P; Thumová M; Dohnalová M; Mullins JJ; Cervenka L
J Hypertens; 2006 Dec; 24(12):2465-72. PubMed ID: 17082731
[TBL] [Abstract][Full Text] [Related]
16. Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension.
Cunningham MW; Sasser JM; West CA; Milani CJ; Baylis C; Mitchell KD
Am J Hypertens; 2013 Oct; 26(10):1242-9. PubMed ID: 23764378
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Prieto MC; Williams DE; Liu L; Kavanagh KL; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F581-8. PubMed ID: 21068087
[TBL] [Abstract][Full Text] [Related]
18. Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension.
Huang L; Howard CG; Mitchell KD
Am J Med Sci; 2012 Oct; 344(4):301-6. PubMed ID: 22261625
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
Ortiz RM; Graciano ML; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1584-91. PubMed ID: 17715265
[TBL] [Abstract][Full Text] [Related]
20. Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.
Howard CG; Mitchell KD
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F52-9. PubMed ID: 21993885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
